JANUMET

Type: Product
Name: JANUMET
First reported 13 hours ago - Updated 13 hours ago - 1 reports

Will These 3 Dividend Stocks Impress Investors This Earnings Season?

Earnings season already has produced its fair share of surprises, but big pharma's hardly even broken out of the gate so far. However, a trio of major drugmakers are set to release their quarterly results in the next two weeks, and all eyes in the sector ... [Published Motley Fool Discussion Boards - 13 hours ago]
First reported Apr 16 2014 - Updated Apr 16 2014 - 1 reports

New report finds Bydureon safest of new class of diabetes drugs

Analysis of FDA adverse event data tries to pull together risks of three new classes of drugsShareToolsBydureon--Courtesy of AstraZenecaWith big money to be made, drugmakers have responded to the global rise in Type 2 diabetes with a host of new classes ... [Published FiercePharma - Apr 16 2014]
First reported Apr 16 2014 - Updated Apr 16 2014 - 1 reports

AdverseEvents' Special Report: Examining the Comparative Safety of Type 2 Diabetes Drugs

Type 2 Diabetes Drugs Safety Review: Byetta Has Best Safety Profile, Nesina Shows Worst Safety ProfileType 2 Diabetes affects approximately 230 million people worldwide and incidence is growing at an alarming rate. To address this epidemic, new drugs ... [Published FiercePharma - Apr 16 2014]
First reported Apr 08 2014 - Updated Apr 08 2014 - 1 reports

Why Big Pharma May Not Be Cashing in on Medical Marijuana

Source: Thinkstock Prohibition against marijuana seems to be soon nearing an end, partially motivated by Colorado’s tax windfall since its passage of Amendment 64 , reporting over $3.5 million in revenue for February from recreational and medical ... [Published Wall St. Cheat Sheet - Apr 08 2014]
First reported Mar 18 2014 - Updated Mar 18 2014 - 1 reports

MLV Sees A Good Chance Of FDA Approval For MannKind's Afrezza And 60% Upside

SummaryIn this interview, MLV's Dr. Graig Suvannavejh discusses his views on the future of MannKind as it gets closer to the upcoming AdCom and PDUFA for Afrezza. Dr. Suvannavejh believes Afrezza has 90% chance of a positive FDA AdCom outcome. Additionally, ... [Published Seeking Alpha - Mar 18 2014]
First reported Mar 17 2014 - Updated Mar 17 2014 - 1 reports

Pharma Summit: Merck’s European president Bruno Strigini highlights importance of innovation

The president of pharma giant Merck & Co’s (NYSE: MRK) operations in Europe and Canada Bruno Strigini spoke about pharma innovation in action at The Economist’s Pharma Summit in London on Thursday.Mr Strigini said that the pharma industry is adapting ... [Published Pharma Letter - Mar 17 2014]
First reported Mar 17 2014 - Updated Mar 17 2014 - 1 reports

New plant in Tuas to produce diabetic drug

DRUG giant Merck Sharp & Dohme will officially open a facility specialising in making the diabetic medication Janumet in Tuas later this year.The plant is part of a US$250million (S$316million) agreement with the Singapore Economic Development Board made ... [Published Biotech Singapore - Mar 17 2014]
First reported Feb 27 2014 - Updated Feb 27 2014 - 1 reports

Januvia Pancreatic Cancer Allegations Help: Resource4thePeople...

National network of lawyers continues offer of complimentary consultations to consumers seeking compensation in lawsuits alleging links between diabetes medications Januvia, Byetta, Janumet and Victoza and pancreatic cancer. http://www.resource4thepe ... [Published PRWeb - Feb 27 2014]
First reported Jan 19 2014 - Updated Jan 19 2014 - 1 reports

Januvia Pancreatic Cancer Allegations Alert: Resource4thePeople...

National network of lawyers will resume availability for inquiries from consumers seeking compensation in lawsuits alleging links between diabetes medications Januvia, Byetta, Janumet and Victoza and pancreatic cancer. http://www.resource4thepeople.c ... [Published PRWeb - Jan 19 2014]
First reported Dec 19 2013 - Updated Dec 19 2013 - 1 reports

Byetta Pancreatic Cancer Allegations Attorneys: Resource4thePeople...

National network of lawyers will continue offer of these consultations through Christmas and New Year’s Day. Allegations involve links between diabetes medications Byetta, Januvia, Janumet and Victoza and pancreatic cancers. http://www.resource4thepe ... [Published PRWeb - Dec 19 2013]
First reported Nov 27 2013 - Updated Nov 27 2013 - 1 reports

Byetta Pancreatic Cancer Allegation Attorneys: Resource4thePeople...

Ruling affects plaintiffs’ claims and response from defendants over allegations that diabetes medications Byetta, Januvia, Janumet and Victoza cause pancreatic cancers. Resource4thePeople lawyers continue to offer free consultations for consumers seeking ... [Published PRWeb - Nov 27 2013]
First reported Nov 05 2013 - Updated Nov 05 2013 - 3 reports

DrugNews Adds Latest Januvia Warnings And Lawsuit News

_ The diabetes drug safety center at DrugNews.net is advising patients taking the medications Januvia or Janumet of updated information on the site. The latest court records from a special federal court show a growing number of patients alleging drugs ... [Published PRWeb - Nov 05 2013]

Quotes

Dr Liew said it could "potentially benefit a lot more people here if it were more affordable"
...about these allegations and their legal options to seek compensation will not be interrupted by the holiday season,” said Resource4thePeople. "In response to numerous inquiries from consumers who have asked about whether our attorneys will be available over the holidays we are announcing that our 24-hour hotline will be staffed for those who may be seeking legal options about their eligibility to seek compensation." The multidistrict litigation in U S District Court for the SouthernSouthern District of California was approved** by a federal judiciary panel because...
...29, 2013, and the defendants must file their master consolidated answer no later than Dec. 31, 2013. "This order was issued after the latest status conference on Nov. 21, 2013, at which the judge was briefed on the progress of the case by attorneys for both sides,” said Resource4thePeople. “The filing of a master complaint will define the allegations in this litigation and the response will provide an answer to the charges from the defendants."
Rudolph Migliore, stated, "While modern medicine has done much to improve the quality of our lives, when defective products or prescription drugs cause unintended consequences, patients suffer unnecessarily from serious injuries." If you or someone you care about was diagnosed with pancreatic cancer after taking the prescription drug Januvia, Janumet, Byetta or Victoza, it is important...

More Content

All (54) | News (50) | Reports (0) | Blogs (3) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Will These 3 Dividend Stocks Impress Investors ... [Published Motley Fool Discussion Boards - 13 hours ago]
New report finds Bydureon safest of new class o... [Published FiercePharma - Apr 16 2014]
AdverseEvents' Special Report: Examining the Co... [Published FiercePharma - Apr 16 2014]
Why Big Pharma May Not Be Cashing in on Medical... [Published Wall St. Cheat Sheet - Apr 08 2014]
Human medicines European public assessment repo... [Published Pending EC decisions and European Public Assess ... - Mar 27 2014]
MLV Sees A Good Chance Of FDA Approval For Mann... [Published Seeking Alpha - Mar 18 2014]
Pharma Summit: Merck’s European president Bruno... [Published Pharma Letter - Mar 17 2014]
New plant in Tuas to produce diabetic drug [Published Biotech Singapore - Mar 17 2014]
Januvia Pancreatic Cancer Allegations Help: Res... [Published PRWeb - Feb 27 2014]
Januvia Pancreatic Cancer Allegations Alert: Re... [Published PRWeb - Jan 19 2014]
TrialNetworks Welcomes Global Pharmaceutical In... [Published PRWeb - Jan 16 2014]
Byetta Pancreatic Cancer Allegations Attorneys:... [Published PRWeb - Dec 19 2013]
Byetta Pancreatic Cancer Allegation Attorneys: ... [Published PRWeb - Nov 27 2013]
DrugRisk November Januvia Update Shows Growth i... [Published PRWeb - Nov 27 2013]
Diabetes and I [Published HealthBoards - Nov 21 2013]
DrugNews Adds Latest Court Update on Januvia La... [Published BioPortfolio - Nov 19 2013]
DrugRisk Adds Latest Court Information For Janu... [Published PRWeb - Nov 13 2013]
DrugNews Adds Byetta Resource Center With Lates... [Published PRWeb - Nov 08 2013]
DrugNews Adds Latest Januvia Warnings And Lawsu... [Published PRWeb - Nov 05 2013]
New York Attorney Now Accepting Januvia, Janume... [Published PRWeb - Nov 05 2013]
Byetta Pancreatic Cancer Allegations Lawyers: R... [Published PRWeb - Nov 05 2013]
DrugNews: Latest Court Records Show Growth of B... [Published PRWeb - Oct 26 2013]
DrugRisk Alerts of Court Update Showing Monthly... [Published PRWeb - Oct 24 2013]
DrugNews: Januvia Lawsuits Alleging Cancer Grow... [Published PRWeb - Oct 24 2013]
PDL BioPharma secures rights to diabetes royalt... [Published Pharmaceutical Technology - Oct 23 2013]
DrugRisk Announces Latest on Lawsuits Alleging ... [Published PRWeb - Oct 15 2013]
Latest Januvia Lawsuits Alleging Pancreatic Can... [Published PRWeb - Oct 14 2013]
DrugNews Alert: Court Sets First Hearing For By... [Published PRWeb - Oct 12 2013]
DrugRisk Update: Court Records Show Cases Growi... [Published PRWeb - Oct 05 2013]
DrugRisk Update: MDL Court Issues Latest on Bye... [Published PRWeb - Sep 27 2013]
1 2
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Why Big Pharma May Not Be Cashing in on Medical... [Published Wall St. Cheat Sheet - Apr 08 2014]
Source: Thinkstock Prohibition against marijuana seems to be soon nearing an end, partially motivated by Colorado’s tax windfall since its passage of Amendment 64 , reporting over $3.5 million in revenue for February from recreational and medical ...
Human medicines European public assessment repo... [Published Pending EC decisions and European Public Assess ... - Mar 27 2014]
Diabetes and I [Published HealthBoards - Nov 21 2013]
Hi,I hail from East India, aged approx. 45 years. Doc prescribed me with T2 Diabetes. Am on medication. Besides Diabetes, I am also hypertensive. Though the Blood Pressure is very much under control, I am advised by my treating Doc to continue with the ...
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.